Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice

Autor: Landis R. Walsh, Chaofan Yuan, James T. Boothe, Heather E. Conway, Andres E. Mindiola-Romero, Odeth O. Barrett-Campbell, Swaroopa Yerrabothala, Frederick Lansigan

Publikováno v: Leukemia Research Reports, Vol 15, Iss , Pp 100251- (2021)

We present the case of a 55-year-old woman who presented with laboratory studies concerning for acute myeloid leukemia (AML) as well as obstructive cholestasis. In similar previously reported cases, concerns of chemotherapy toxicity exacerbated by li

Externí odkaz: https://doaj.org/article/6784319e32a84e1d9b0c972fd55f284a

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.

Autor: Samples L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Fakhri B; Division of Hematology and Oncology, University of California, San Francisco, CA., Khajavian S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Spurgeon S; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR., Stephens D; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Skarbnik A; Novant Health, Charlotte, NC., Mato A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Broome C; Division of Hematology and Oncology, Georgetown University, Washington, DC., Gopal A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Smith S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Lynch R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Rainey M; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Kim MS; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR., Barrett-Campbell O; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Hemond E; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Tsang M; Division of Hematology and Oncology, University of California, San Francisco, CA., Ermann D; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Malakhov N; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY., Rao D; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Shakib-Azar M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Morrigan B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Chauhan A; Division of Hematology and Oncology, Georgia Cancer Center, Augusta University, Augusta, GA., Plate T; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Gooley T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Ryan K; AstraZeneca, Gaithersburg, MD., Lansigan F; Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Hill B; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Pongas G; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Parikh SA; Department of Hematology, Mayo Clinic, Rochester, MN., Roeker L; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY., Cheng R; Division of Cardiology, University of Washington, Seattle, WA., Ujjani C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.

Publikováno v: Blood advances [Blood Adv] 2024 May 14; Vol. 8 (9), pp. 2085-2093.

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

Autor: Orellana-Noia VM; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Reed DR; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.; Comprehensive Cancer Center of Wake Forest University, Section on Hematology and Oncology, Winston-Salem, NC., McCook AA; Winship Cancer Institute, Department of Biostatistics, Emory University, Atlanta, GA., Sen JM; Department of Pharmacy, University of Virginia, Charlottesville, VA., Barlow CM; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Malecek MK; Department of Medicine, Washington University School of Medicine, St Louis, MO., Watkins M; Department of Medicine, Washington University School of Medicine, St Louis, MO., Kahl BS; Department of Medicine, Washington University School of Medicine, St Louis, MO., Spinner MA; Division of Oncology, Stanford University Medical Center, Stanford, CA., Advani R; Division of Oncology, Stanford University Medical Center, Stanford, CA., Voorhees TJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.; Division of Hematology, Ohio State University, Columbus, OH., Snow A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Grover NS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Ayers A; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Romancik J; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Liu Y; Division of Hematology, Yale University, New Haven, CT., Huntington SF; Division of Hematology, Yale University, New Haven, CT., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Saeed H; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Lazaryan A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Raghunathan V; Division of Hematology and Oncology, Oregon Health Sciences University, Portland, OR.; Division of Medical Oncology, University of Washington, Seattle, WA., Spurgeon SE; Division of Hematology and Oncology, Oregon Health Sciences University, Portland, OR., Ollila TA; Division of Hematology/Oncology, Brown University, Providence, RI., Del Prete C; Division of Hematology/Oncology, Brown University, Providence, RI., Olszewski A; Division of Hematology/Oncology, Brown University, Providence, RI., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Echalier B; Division of Hematology, University of Colorado, Denver, CO., Lee J; Division of Hematology, University of Colorado, Denver, CO., Kamdar M; Division of Hematology, University of Colorado, Denver, CO., Caimi PF; Adult Hematologic Malignancies and Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH.; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Fu T; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Liu J; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., David KA; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ., Alharthy H; Department of Medicine, University of Maryland Medical Center, Baltimore, MD., Law J; Division of Hematology and Oncology, University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore, MD., Karmali R; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Shah H; University of Utah/Huntsman Cancer Institute, Salt Lake City, UT., Stephens DM; University of Utah/Huntsman Cancer Institute, Salt Lake City, UT., Major A; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Rojek AE; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Smith SM; Section of Hematology/Oncology, University of Chicago, Chicago, IL., Yellala A; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE., Kallam A; Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE., Nakhoda S; Fox Chase Cancer Center, Philadelphia, PA; and., Khan N; Fox Chase Cancer Center, Philadelphia, PA; and., Sohail MA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Barrett-Campbell O; Division of Hematology and Oncology, Dartmouth Geisel School of Medicine, Hanover, NH., Lansigan F; Division of Hematology and Oncology, Dartmouth Geisel School of Medicine, Hanover, NH., Switchenko J; Winship Cancer Institute, Department of Biostatistics, Emory University, Atlanta, GA., Cohen J; Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA., Portell CA; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.

Publikováno v: Blood [Blood] 2022 Jan 20; Vol. 139 (3), pp. 413-423.

Prevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease.

Autor: McFarlane IM; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Ozeri DJ; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Pathiparampil J; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Sanchez R; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Levinson J; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Barrett-Campbell O; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Saladini-Aponte C; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Boisette B; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA., Salifu M; Department of Medicine, Division of Rheumatology and Nephrology, State University of New York, Downstate Medical Center/Health and Hospitals Kings County Brooklyn, USA.

Publikováno v: Rheumatology (Sunnyvale, Calif.) [Rheumatology (Sunnyvale)] 2017 Jun; Vol. 7 (2). Date of Electronic Publication: 2017 Apr 28.